Press Releases July 16, 2026 08:00 AM

CareCloud to Announce Second Quarter 2026 Results on August 6, 2026

CareCloud to report Q2 2026 financial results on August 6, 2026

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
CCLD

CareCloud, Inc., a leader in AI-powered healthcare technology and revenue cycle management, announced it will release its financial results for the second quarter ended June 30, 2026 on August 6, followed by an investor conference call. The company serves over 45,000 providers with solutions that enhance financial and operational healthcare performance.

CareCloud to Announce Second Quarter 2026 Results on August 6, 2026
CCLD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CareCloud provides AI and technology-enabled solutions to improve operational efficiency and patient care for medical practices and health systems.
  • The company will report its Q2 2026 financial results ahead of market open on August 6, 2026, with a subsequent investor conference call.
  • CareCloud's offerings impact healthcare providers by improving revenue cycle management, clinical workflows, and patient experience management.

SOMERSET, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing “CareCloud, Inc. Second Quarter 2026 Results Conference Call” or click the Call Me link for instant telephone access. Investors who opt for audio-only will need to download the related slides at ir.carecloud.com/events.

A replay of the conference call and related presentation slides will be available approximately three hours after conclusion of the call at the same link. An audio-only option can also be accessed by dialing 412-317-6671 and providing the access code 13761329.

About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.

Follow CareCloud on LinkedIn, X and Facebook.

For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

SOURCE CareCloud

Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
[email protected]

Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
[email protected]


Risks

  • Financial performance uncertainties inherent in quarterly earnings reports that may differ from market expectations potentially impacting stock price.
  • Dependence on healthcare sector adoption of AI and technology solutions, which could be affected by regulatory, market or implementation challenges.
  • Competitive pressures in healthcare technology and revenue cycle management markets may impact growth and profitability.

More from Press Releases

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM Aug 30, 2026 Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026